Left Sided Heart Failure EMS 210 Left Sided Heart Failure Left sided heart failure is among the most common chronic illnesses and is a precipitating factor in many patient encounters in prehospital medicine. There are an estimated 6.5 million Americans over the age of 20 currently diagnosed with some form of heart failure and an estimated 965,000 new cases annually (Heart Failure Society of America, n.d.). Heart failure is also a major killer of Americans and is estimated to be the principal killer in 8.5% of all heart disease deaths, some estimates even put heart disease as playing a major role in up to 36% of all cardiovascular related deaths. (Heart Failure Society of America, n.d.). With heart failure afflicting such a large portion of Americans, and making up a very sick patient population with the potential to require emergent prehospital intervention, it is a condition that can rapidly progress into a multisystemic issue right in front of the pre-hospital provider. In an article of the journal of resuscitation they note a finding in a Western Australian study; of EMS witnessed out-of-hospital cardiac arrests(OHCA) deemed cardiac related 82% had pre existing heart disease, They note that EMS witnessed OHCA had a higher incidence of being related to a pre-existing diagnosis. (Holmstrom, 2022, 19-27). This paper will outline the Pathophysiology, Clinical presentation, and pre-hospital treatment of CHF, with an emphasis on left sided failure in an effort to better understand and treat a common and sick patient population. Pathophysiology and Diagnosis The left ventricle is the largest chamber in the human heart due to its important responsibility of driving and maintaining systemic circulation. Ejection Fraction(EF) is the measurement of blood ejected out of the left ventricle during systole compared to the amount of blood contained within the left ventricle measured as a percent. A healthy left ventricle will eject 55%-60% of the blood pumped into it per cycle. Left sided Heart Failure is commonly divided into 2 different types, Systolic and Diastolic. Systolic heart failure occurs when the the left ventricle’s ability to contract normally is inhibited, this will result in a decrease of blood being ejected into systemic circulation, Systolic left sided heart failure is considered to be occurring when EF decreases to 40% or less and it is also known as left sided heart failure with reduced EF. Diastolic heart failure occurs when the left ventricle’s ability to relax is inhibited, resulting in reduced capability of the left ventricle to refill. Diastolic heart failure typically will present with intact or slightly reduced EF. As such, diastolic heart failure is also known as Left sided heart failure with preserved or mid-ranged EF, depending on if the EF is maintaining above 50% or somewhere in between 41% and 49%. The greatest concern to prehospital providers is that both types of left sided heart failure (Either due to decreased refilling or EF) can cause blood to backflow from the left ventricle into the pulmonary circuit, when the pressure within the pulmonary vasculature increases, plasma may begin to extravasate into the lower airways, this is referred to as pulmonary edema, This may happen acutely such as in Sympathetic crashing acute pulmonary edema(SCAPE) or over a prolonged period of time such as in Fluid overload sub-acute pulmonary edema(FOSPE). Prehospital providers should be cognizant of both conditions, however SCAPE will typically result in a rapid downward progression due to its self perpetuating mechanism. Activation of the sympathetic nervous system will result in a catecholamine release that increases cardiac afterload, this exacerbates heart failure and increases the workload of the already inhibited left ventricle which causes an increase in backflow resulting in pulmonary fluid overload and dyspnea, which causes the patient distress and further catecholamine release which will perpetuate a cycle, as such SCAPE patients will rapidly progress into severe cardiogenic shock and respiratory failure over a period of minutes to hours (Farkas, 2021). Left sided heart failure is also the most typical cause of right sided heart failure leading to more compounding multisystemic issues (Right-Sided Heart Failure Information, n.d.). Left sided heart failure is precipitated by many common age related risk factors and comorbidities, lending to its prevalence in the geriatric population. Common etiologies and risk factors to be aware of include, Deconditioning or frailty syndromes, a history of cardiovascular diseases, especially a history of MI or ACS, hypertension and coronary artery disease, non cardiovascular disorders that increase cardiac workload such as chronic kidney disease, anemia and liver disease, And Polypharmacy, also look for any conditions that may acutely increase cardiac workload or exacerbate cardiac backflow such as sympathetic nervous activation, afib with rvr or new onset atrial fibrillation (Hurtado & Gelfand, 2024). Diagnosis is typically achieved using direct cardiac testing such as ECG and echocardiography or presence of cardiac biomarkers in bloodwork. Prehospital Assessment and Treatment of Left Sided Heart Failure Prehospital Assessment The greatest concern related to left sided heart failure to the prehospital provider will be the backflow of blood into pulmonary circulation, specifically SCAPE, which may require emergent proactive treatment to stop its rapid progression. The prehospital provider should be able to differentiate between SCAPE and FOSPE patients when responding to suspected CHF related dyspnea and keep in mind other possible differentials in order to adequately treat this patient population. Clinical Presentation CHF often will present similarly across age ranges, prehospital providers should take note of and assess for History of Present Illness ● Dyspnea on exertion ● Orthopnea (Palliated by upright positioning and often exacerbated by supine positioning) ● Rapid fatigability ● Sudden or recent exposure to a stressful event or a recent onset of emotional distress ● Consider investigating the possibility of concurrent ACS. Physical Assessment ● Lung sounds indicative of fluid (crackles, rales) typically will be bilateral and most extreme in the lower lobes ● Pink, frothy productive cough ● Look for clinical indications of sympathetic activation (Anxiety,Agitation, diaphoresis, tachycardia) ● Hypertension ● Hypoxemia ● Jugular Venous Distension (note that pulmonary edema patients may be hypervolemic, normovolemic or hypovolemic and presence or absence of JVD is not a reliable indicator of severity) ● Atrial fibrillation with RVR or new onset Atrial Fibrillation ● Pitting edema Differential Diagnosis Always remember to keep in mind other possible causes of SOB with the presence of rales or crackling lung sounds. Always consider infectious causes, such as pneumonia, as they will have different and possibly opposing treatment pathways. Environmental causes, such as trauma and aspiration, are also possible. Noncardiogenic pulmonary edema is also a noted side effect of chronic kidney disease and pancreatitis (Abughazaleh, 2024, 931). Prehospital treatment Prehospital management of left sided heart failure will depend on local protocol, however treatment will typically revolve most heavily on management of respiratory insufficiency and ruling out any other factors that may be exacerbating the condition such as cardiogenic shock due to ACS. It is important to quickly establish the severity of the episode and consider a more proactive treatment approach as opposed to a reactive one when managing SCAPE patients or any rapidly progressing pulmonary edema. The first step in treatment is always to ensure a patent airway followed by any emergent management of breathing or circulatory status (e.g respiratory arrest, severe hypoxia, life threatening arrhythmias). Once the primary assessment is cleared, or managed treatment of the specific disease may begin. The gold standard treatment of acute decompensated pulmonary edema prehospitally is PAP therapy and nitrates. It is best practice to also equip a cardiac monitor and obtain a 12 lead ECG, in the future Point of care ultrasound (POCUS) may also become an option prehospitally. Other prehospital treatments that have begun to lose favor in recent years may include loop diuretics and morphine. PAP Therapy The universal standard of care for decompensating heart failure patients is positive airway pressure(PAP), use of PAP therapy has shown a decrease in rates of intubation and overall 30 day mortality (Kato, 2014, 1175-1191) and is the prehospital providers best tool in managing acute pulmonary edema. PAP therapy works through the induction of positive pressure, most beneficially on exhalation, causing an increase in intrathoracic pressure thereby reversing atelectasis, allowing for more alveolar surface area for gas exchange, and through managing hydrostatic pressure, pushing any fluid in the lungs out into the interstitial spaces. PAP therapy should be applied quickly when indicated however not before an assessment has occurred as there are absolute contraindications to PAP therapy. PAP therapy may cause a decrease in venous return to the heart which may exacerbate hypotension and could further complicate preload dependent cardiogenic shock. Recent airway or Gastrointestinal surgery is also an absolute contraindication. Care should be exercised when administering PAP therapy in patients presenting with altered mental status or reduced ability to protect their own airway. The most commonly available form of PAP therapy prehospitally is continuous positive airway pressure(CPAP). CPAP therapy is in no way equivalent to mechanical ventilation and is not appropriate for patients requiring artificial ventilations. For patients requiring artificial ventilation consider intubation and/or adjusting positive end expiratory pressure settings on your BVM or ventilator. Nitrates The efficacy of administration of nitrates in supporting acute heart failure treatment is unclear however the best results have come from early administration of high dose nitrates (Alzahri, 2016, 51-55), This puts prehospital providers in a unique position to possibly improve patient outcome through early recognition and rapid intervention, as without these the efficacy of nitrates in acute heart failure in the literature is not well supported. The most commonly available prehospital nitrate is nitroglycerin; it works through a long series of reactions originating at the cellular level and results in systemic vasodilation. The main goal of nitrate administration in acute heart failure is to reduce ventricular filling pressure and cardiac afterload to reduce backflow and increase cardiac output (Alzahri, 2016, 51-55). While the literature does support early administration keep in mind that nitroglycerin still has absolute contraindications, it should not be used in hypotensive patients or patients who have taken PDE-5 inhibitors (e.g Viagra, tadalafil, Cialis etc.) in the last 24 to 48 hours, note that while PDE-5 inhibitors are most commonly prescribed to men for erectile dysfunction, any patient of any age and either sex may be taking these medications as they do have uses outside of sexual dysfunction. Nitrates should also be administered with caution in preload-dependent cardiogenic shock due to their decrease in cardiac preload. When used concurrently with PAP therapy, this effect will be compounded. Loop Diuretics & Morphine Prehospital administration of loop diuretics, most commonly Furosemide, has fallen out of favor in recent practice. The FAST-FURO study conducted in 2021 found no effect in pre-hospital administration of furosemide on short stay mortality or length of stay (Miro, 2021). A smaller study published in 2015 even found that over 33% of patients who received furosemide prehospitally did not even have a diagnosis of heart failure (Pan,2015). Lack of evidence for its efficacy and its relatively long time to peak serum level has resulted in Lasix being pulled from ambulances in most of the US. Morphine is another significantly popular treatment for acute heart failure and is widely available in most EMS systems; however, the scientific backing for its efficacy in treating acute heart failure is lacking at best and shows possible harm at worst (Agewall, S. 2017). It is believed that morphine’s ability to reduce vascular tone through an indirect histamine agonizing effect may provide a benefit similar to nitrates however, it has also been found to have a depressing effect on the myocardium which decreases cardiac output and may worsen severe CHF (Agewall, S. 2017). A 2008 meta-analysis even found an increase in adverse events and increase in overall mortality in patients who received morphine as treatment for acute heart failure (Peacock, W. 2008) POCUS There is little research on the use of POCUS prehospitally for acute heart failure however as POCUS becomes more and more widespread it may open up a new way to effectively treat patients, for example POCUS may help quickly differentiate between heart failure with reduced or preserved EF, opening up the possibility of afterload reduction treatments. There also have been several instances of CHF being misdiagnosed as asthma or COPD, prehospital identification of b-lines and other visual artifacts indicative of fluid present in the lungs on ultrasound may help begin effective treatment sooner in the undifferentiated shortness of breath patient. Conclusion Left sided heart failure is a condition that should be understood inside and out by prehospital providers due to its high prevalence and the possibility of it becoming life threatening quickly and without warning. Distinction should be drawn between SCAPE and FOSPE patients, application of interventions and aggressive management should be initiated quickly when identifying SCAPE. References Abughazaleh, S. (2024). Pulmonary Edema. In Ferri's Clinical Advisor 2025 (p. 931). Alzahri, M. S. (2016). Nitrates as Treatment of Acute Heart Failure. Cardiac Failure Review, 2(1), 51-55. NCBI. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490950/ Farkas, J. (2021, August 30). Sympathetic Crashing Acute Pulmonary Edema (SCAPE). EMCrit Project. Retrieved July 10, 2024, from https://emcrit.org/ibcc/scape/ Heart Failure Society of America. (n.d.). Heart Failure Facts & Information. Heart Failure Facts & Information. Retrieved July 10, 2024, from https://hfsa.org/patient-hub/heart-failure-facts-information Holmstrom, L. (2022). Out-of-hospital cardiac arrest with onset witnessed by emergency medical services: Implications for improvement in overall survival. Resuscitation, 175, 19. Elsevier. https://www.clinicalkey.com/#!/content/journal/1-s2.0-S030095722200106X?scrollTo=% 23hl0000234 Hurtado, G. P., & Gelfand, E. (2024). Heart failure in Older Adults [Clinical Overview]. https://www.clinicalkey.com/#!/content/clinical_overview/67-s2.0-MC147#etiology-andrisk-factors-heading-hd008 Kato, T. (2014). Positive airway pressure therapy in heart failure. World Journal of Cardiology, 6(11), 1175-1191. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244615/ Right-Sided Heart Failure Information. (n.d.). Columbia Doctors. Retrieved July 10, 2024, from https://www.columbiadoctors.org/health-library/article/right-sided-heart-failure/ Miró, Ò., Harjola, P., Rossello, X., Gil, V., Jacob, J., Llorens, P., … ICA-SEMES Research Group. (2021). The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department. European Heart Journal. Acute Cardiovascular Care, 10(5), 487–496. doi:10.1093/ehjacc/zuaa042 Pan, A., Stiell, I. G., Dionne, R., & Maloney, J. (2015). Prehospital use of furosemide for the treatment of heart failure. Emergency medicine journal : EMJ, 32(1), 36–43. https://doi.org/10.1136/emermed-2013-202874 Agewall, S. (2017). Morphine in acute heart failure. Journal Of Thoracic Disease, 9(7), doi:10.21037/jtd.2017.06.129 Peacock WF, Hollander JE, Diercks DB, et alMorphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emergency Medicine Journal 2008 25:205-209. Case Series: Prehospital POCUS Aides in Shortness of Breath Diagnosis. (2023, January 30) Januaryhttps://www.emra.org/emresident/article/prehospital-shortness-of-breath
0
You can add this document to your study collection(s)
Sign in Available only to authorized usersYou can add this document to your saved list
Sign in Available only to authorized users(For complaints, use another form )